FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

SOMANYCERA Consensus Forecast

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
250
Consensus Potential
-140.52%

SOMANYCERA Price Target Potential

BrokerageTargetPotential

SOMANYCERA Targets in FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for SOMANYCERA
0% Bullish
0% Bearish
See buy or sell ideas on FrontPage Forums >>

SOMANYCERA Ratings

Long term SOMANYCERA rating by FrontPage users
4.3/5 (3 Ratings)

1 SOMANYCERA share price target reports by brokerages below. See what is analyst's view on SOMANYCERA share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. SOMANYCERA Forum
  3. SOMANYCERA Price Target

SOMANYCERA Share Price Target

SOMANYCERA Share Price Target - Broker Reports - 2019

9-Sep-19
Price @ Call: 242.85
Target: 250
HOLD
Somany has become operationally strong with credit control measures taken in FY19. Overall, while the business environment remains challenging amid liquidity squeeze in the economy, Somany is expected to perform relatively better than its peers. Thus, we expect PAT to grow at 23.7% CAGR to Rs 70.9 crore in FY19-21E. On the flip side, recent broker-related defaultlends us discomfort over the company’s profitability as it is the second instance after the company took provisions worth Rs 15.9 crore in FY19 on account of misappropriation of funds by an employee. Also, Somany has investment of Rs 29.9 crore in Srei Infrastructure Finance in form of NCDs, of which Rs 11.1 crore will mature on March 23, 2020. The financial performance of Srei Infra Finance is deteriorating, which remains a concern for Somany’sinvestment. Overall, we cut our target multiple and downgrade the stock to HOLD with a revised target price of Rs 250/share (15x FY21E EPS).
... Read more
8-Aug-19
Price @ Call: 314.47
Target: 400
BUY
With the addition in value added capacities and stress in Morbi cluster, the management has guided for double digit volume and sales growth in FY20E. At CMP of INR 319, the stock is trading at 18XFY20E and 12XFY21E earnings. We maintain a BUY rating on the stock with a target price to INR 400 based on a target P/E of 15XFY21EPS. Risks: Sharp increase in power & fuel cost. Prolonged slowdown in the construction activity could adversely affect the tile demand.
... Read more
6-Aug-19
Price @ Call: 321.39
Target: 370
BUY
Somany has become operationally strong with credit control measures taken in FY19. Nonetheless, the overall business environment remains challenging amid liquidity squeeze in the economy. Hence, we revise our earnings estimates downward. We now expect PAT to grow at 26.6% CAGR to | 74.3 crore in FY19-21E. We maintain BUY recommendation on the stock with a target price of | 370/share (21x FY21E EPS).
... Read more
24-May-19
Price @ Call: 388.95
Target: 475
BUY
Somany has become structurally strong with credit control measures taken in FY19. Additional value-added capacities & stress in Morbi cluster could not only lead Somany to clock double-digit growth in FY20E but could also lead to PAT growth of 40.8% CAGR to | 91.9 crore in FY19-21E. We maintain BUY recommendation on the stock with a target price of Rs 475/share.
... Read more
18-Feb-19
Price @ Call: 309.85
Target: 380
BUY
Persistent cost pressure and subdued realisation have been the major drags on SOMC’s performance for last one year. Looking ahead, we believe that improved product-mix, recent price hikes (in Ceramic & PVT and Sanitaryware segments) and steady reduction in gas prices are likely to aid its operating performance. Following sharp correction in stock price in last 12 months, current valuation at 15x of FY21 earnings appears to be attractive. Marginally reducing our target multiple to 18x (from 20x earlier) due to contraction in return ratio, we maintain our BUY recommendation on the stock with a revised Target Price of Rs380 (18x FY21 EPS).
... Read more
13-Feb-19
Price @ Call: 322.16
Target: 410
BUY
Currently, Somany is trading at 15.5x FY20E EPS, at ~40% discount to Kajaria. In our view, this current valuation discount has widened (15-20% historically) on account of Somany underperformance following operational disruptions & credit control measures. Going ahead, Somany’s financial performance is set to improve with steady improvement in demand and sharp recovery in EBITDA margins. Also, the anticipated improvement in financial performance should narrow down valuation gap between Somany & Kajaria, going ahead. Hence, we maintain our BUY rating, with a target price of Rs 410/share (20x FY20E EPS).
... Read more

SOMANYCERA Share Price Target - Broker Reports - 2018

27-Dec-18
Price @ Call: 326.84
Target: 410
BUY
27-Nov-18
Price @ Call: 290.3
Target: 375
BUY
10-Aug-18
Price @ Call: 491.45
Target: 520
HOLD
3-Jul-18
Price @ Call: 499
Target: 822
BUY
27-Jun-18
Price @ Call: 521.45
Target: 611
ACCUMULATE
2-Feb-18
Price @ Call: 730
Target: 1100
BUY

SOMANYCERA Share Price Target - Broker Reports - 2017

21-Nov-17
Price @ Call: 863.94
Target: 1000
BUY
21-Nov-17
Price @ Call: 863.94
Target: 900
HOLD
21-Nov-17
Price @ Call: 842
Target: 900
BUY
19-Sep-17
Price @ Call: 814.55
Target: 967
BUY
12-Sep-17
Price @ Call: 810
Target: 1020
BUY
28-Aug-17
Price @ Call: 801
Target: 880
BUY
21-Aug-17
Price @ Call: 782
Target: 815
HOLD
26-May-17
Price @ Call: 781
Target: 885
BUY
25-May-17
Price @ Call: 751
Target: 921
BUY

SOMANYCERA Share Price Target - Broker Reports - 2016

26-May-16
Price @ Call: 478
Target: 540
BUY
28-Oct-16
Price @ Call: 657
Target: 680
BUY
10-Aug-16
Price @ Call: 599
Target: 610
HOLD
8-Jul-16
Price @ Call: 580.15
Target: 615
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • SOMANYCERA Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3629.2
    Upside Target 2619.1
    Upside Target 1610.2
    Pivot600.1
    Downside Target 1591.2
    Downside Target 2581.1
    Downside Target 3572.2
  • SOMANYCERA Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3800
    Upside Target 2708
    Upside Target 1653.45
    Pivot561.45
    Downside Target 1506.9
    Downside Target 2414.9
    Downside Target 3360.35
  • SOMANYCERA Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3582.87
    Upside Target 2535.43
    Upside Target 1502.32
    Pivot454.88
    Downside Target 1421.77
    Downside Target 2374.33
    Downside Target 3341.22
  • SOMANYCERA Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3619.1
    Upside Target 2611.84
    Upside Target 1607.36
    Pivot600.1
    Downside Target 1592.84
    Downside Target 2588.36
    Downside Target 3581.1
  • SOMANYCERA Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3708
    Upside Target 2652.02
    Upside Target 1617.43
    Pivot561.45
    Downside Target 1505.47
    Downside Target 2470.88
    Downside Target 3414.9
  • SOMANYCERA Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3535.43
    Upside Target 2504.66
    Upside Target 1485.65
    Pivot454.88
    Downside Target 1424.11
    Downside Target 2405.1
    Downside Target 3374.33
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020